Clinical Trials in Tennessee

Showing 1961-1980 of 17,345 trials

Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.

NCT06858319

The purpose of this study is to determine if zigakibart is safe and effective for long-term use in patients with immunoglobulin A nephropathy (IgAN). This is an extension study for patients who have already completed an another zigakibart study.

Kidney DiseasesKidney Diseases, ChronicUrological Diseases+5 more

Novartis Pharmaceuticals220 participantsStarted Jul 2025

Denver, Colorado, United States • Clifton Park, New York, United States • Brentwood, Tennessee, United States +3 more locations

Active Not RecruitingPhase 229 miles

A Study of Abemaciclib (LY2835219) Plus Tamoxifen or Abemaciclib Alone in Women With Metastatic Breast Cancer

NCT02747004

The main purpose of this study is to evaluate the safety and efficacy of abemaciclib plus tamoxifen or abemaciclib alone in women with previously treated hormone receptor-positive (HR+), human epidermal growth factor receptor 2 negative (HER2-), metastatic breast cancer.

Metastatic Breast Cancer

Eli Lilly and Company234 participantsStarted Sep 2016

Tucson, Arizona, United States • Lebanon, New Hampshire, United States • Nashville, Tennessee, United States +56 more locations

Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.

A Study of Abemaciclib (LY2835219) Plus Tamoxifen or Abemaciclib Alone in Women With Metastatic Breast Cancer

Find Trials by Condition in Tennessee

Dopaminergic Dysfunction in Late-Life Depression

A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies

A Study of TAK-188 in Adults With Advanced or Spreading Solid Tumors

A Longitudinal Observational Study of the Natural History and Management of Patients With HCC

A Study to Learn About the Study Medicine Called PF-07976016 in Adults With Obesity

Study of Efficacy and Safety of Investigational Treatments in Patients With Moderate to Severe Hidradenitis Suppurativa

DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors

CLOZAPINE Response in Biotype-1

Buprenorphine Extended-Release Subcutaneous Injection (RBP-6000) in High-risk Users

A Study to Evaluate the Safety and Effectiveness of the Rapidlink Device When Used in Patients Undergoing an Open Surgical Procedure to Repair the Aorta

Expanded Access Protocol (EAP) for Nonconforming (NC) Afami-cel

An Open-Label Phase 1/2 Study of Itacitinib in Combination With Osimertinib in Subjects With Non-Small Cell Lung Cancer

Acalabrutinib With or Without Obinutuzumab in Treating Patients With Early-Stage Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Pertuzumab, Trastuzumab, Hyaluronidase-zzxf and Enzalutamide for Treatment of Metastatic Castration-Resistant Prostate Cancer

A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer

A Study of Breast Cancer Risk Factors and Outcomes of People in Florida

PrEP Affect Regulation Treatment Innovation

Study of ARO-DUX4 in Adult and Adolescent Patients With Facioscapulohumeral Muscular Dystrophy Type 1